DAPPAR AF Dabigatran for Peri Procedural Anticoagulation During Radiofrequency Ablation of Atrial Fibrillation

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 13, 2011

Primary Completion Date

January 31, 2017

Study Completion Date

June 7, 2017

Conditions
Atrial Fibrillation
Interventions
DRUG

dabigatran

30 days pre ablation and 90 days post ablation

Trial Locations (1)

N6A 5A5

London Health Sciences Center, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT01468155 - DAPPAR AF Dabigatran for Peri Procedural Anticoagulation During Radiofrequency Ablation of Atrial Fibrillation | Biotech Hunter | Biotech Hunter